• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VALITUDE CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VALITUDE CRT-P; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P) Back to Search Results
Model Number U125
Device Problems Under-Sensing (1661); Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/07/2023
Event Type  malfunction  
Event Description
It was reported that this cardiac resynchronization therapy pacemaker (crt-p), implanted with another manufacturer's right atrial (ra) lead, exhibited undersensing of atrial flutter.Every other beat was in refractory with some falling into blanking, resulting in a lack of mode switching.The arrhythmia was not chronic and converted while the patient was in the clinic.In addition, the atrial tachy response (atr) trigger rate was set to 150 bpm and the atrial flutter rate was slightly less at 145 bpm.It was noted that lowering the atr trigger rate to 140 bpm and decreasing atrial blanking after ventricular pace to 85 ms still did not allow mode switching.Technical services (ts) reviewed additional programming options.This crt-p remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event Description
It was reported that this cardiac resynchronization therapy pacemaker (crt-p), implanted with another manufacturer's right atrial (ra) lead, exhibited undersensing of atrial flutter.Every other beat was in refractory with some falling into blanking, resulting in a lack of mode switching.The arrhythmia was not chronic and converted while the patient was in the clinic.In addition, the atrial tachy response (atr) trigger rate was set to 150 bpm and the atrial flutter rate was slightly less at 145 bpm.It was noted that lowering the atr trigger rate to 140 bpm and decreasing atrial blanking after ventricular pace to 85 ms still did not allow mode switching.Technical services (ts) reviewed additional programming options.This crt-p remains in service.No adverse patient effects were reported.Additional information received reported that this crt-p was explanted and replaced due to normal battery depletion (nbd).No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALITUDE CRT-P
Type of Device
PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17188127
MDR Text Key317919032
Report Number2124215-2023-32670
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526559389
UDI-Public00802526559389
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030005/S113
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/04/2018
Device Model NumberU125
Device Catalogue NumberU125
Device Lot Number702565
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/07/2023
Initial Date FDA Received06/22/2023
Supplement Dates Manufacturer Received07/28/2023
Supplement Dates FDA Received08/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age61 YR
Patient SexFemale
-
-